NEW YORK, Jan 9 – Nanogen announced Tuesday it will post lower-than-expected fourth-quarter revenues due to lowered sales of NanoChip custom electronic microarray cartridges, but noted it had shipped 16 NanoChip molecular biology workstations during the quarter and that its losses for the fourth quarter would remain in line with Wall Street’s expectations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.